Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Randall Michael Giuffre Insider Profile
4 Followers
Randall Michael Giuffre, Director at Diamedica Therapeutics, holds 411.19K shares in Diamedica Therapeutics (Ticker: DMAC).
Randall Michael Giuffre has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Randall Michael Giuffre's holdings
Insider Roles
Director
Roles that Randall Michael Giuffre holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Randall Michael Giuffre
Randall Michael Giuffre's Trading History
List of latest transactions for each holding click on a transaction to see Randall Michael Giuffre's performance on stock
You May Also Like
Randall Michael Giuffre insider profile FAQ
What is the percentage of profitable transactions made by Randall Michael Giuffre?
The percentage of profitable transactions made by Randall Michael Giuffre is ―.
What is the average return per transaction made by Randall Michael Giuffre?
The average return per transaction made by Randall Michael Giuffre is ―.
What stocks does Randall Michael Giuffre hold?
Randall Michael Giuffre holds: DMAC stocks.
What was Randall Michael Giuffre’s latest transaction?
Randall Michael Giuffre latest transaction was an Uninformative Buy of $53.75K.
What was Randall Michael Giuffre's most profitable transaction?
Randall Michael Giuffre’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Randall Michael Giuffre's role in Diamedica Therapeutics?
Randall Michael Giuffre's role in Diamedica Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.